Mary Kay Patents Topical To Treat Telangiectasia

US Patent No. 9,526,689 B2; Mary Kay  has patented a method of treating telangiectasia with a topical composition that is comprised of an alcoholic extract of Centella asiactica leaf; an aqueous extract of Vitis vinifera seed; an alcoholic, hydro-alcoholic, or aqueous extract of Magnolia grandiflora bark; an alcoholic, hydro-alcoholic, or aqueous extract of Camellia sinensis leaf; and dihydroxymethylchromone. The Centella asiactica leaf and Vitis vinifera seed extracts disrupt endothelia tubes in skin.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters